Visbiome
Sponsors
University Health Network, Toronto, Ashok Tuteja, University of Louisville, Medical College of Wisconsin, University of Washington
Conditions
AgingAlcohol DrinkingColorectal CancerDepressionGulf War IllnessHIV-1 InfectionMetabolismType 1 Diabetes
Early Phase 1
Phase 2
Probiotic Visbiome for Inflammation and Translocation in HIV II
NCT02441231
Start: 2015-11-30End: 2019-05-31Target: 36Updated: 2018-04-18
Probiotic Visbiome for Inflammation and Translocation in HIV Ι
TerminatedNCT02441244
Start: 2015-11-15End: 2016-12-19Updated: 2018-03-01
Probiotic (Visbiome) for Gulf War Illness
NCT03078530
Start: 2013-09-13End: 2018-05-31Target: 60Updated: 2017-12-13
Probiotics in Newly Diagnosed T1D
Active, not recruitingNCT04141761
Start: 2019-04-01End: 2027-06-30Updated: 2025-10-16
Unknown Phase
Visbiome Effect on Colorectal Anastomosis and Local Recurrence
WithdrawnNCT03524638
Start: 2018-04-13End: 2019-07-29Updated: 2021-07-16
Impact of Probiotics on Drug, Vitamin, and Hormone Metabolism
NCT04281407
Start: 2020-01-03End: 2020-08-31Target: 12Updated: 2020-02-24
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RecruitingNCT07415707
Start: 2026-02-26End: 2027-04-30Target: 20Updated: 2026-03-04